✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Advanced Enzyme Technologies Ltd.

ADVENZYMES

Market Cap
₹4,178 Cr.
P/E
24.77

Advanced Enzyme Technologies Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
4,178 Cr
PE
PE
24.77
Prom Holding
Prom Holding
43.26 %
ROE (%)
ROE (%)
9.23
ROCE (%)
ROCE (%)
12.68
Div Yield (%)
Div Yield (%)
0.36
Sales
Sales
745 Cr
OPM (%)
OPM (%)
30.72 %
Debt to Equity
Debt to Equity
0.02
Institutions
Institutions
30.90 %
Individual < 2 lac
Individual < 2 lac
16.22 %
No. of Shareholders
No. of Shareholders
66,193
View more
Edit Ratio's

About

Advanced Enzymes Technologies Limited is a global leader in enzymes and probiotics manufacturi… Read more
Low
252
52W Range
High
419
  • Advanced Enzyme
  • Fermenta Biotech
  • Concord Biotech
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

10 %
(as of Mar 18)
Source/Historic
Nutraceuticals Segment Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Advanced Enzyme Technologies Ltd. Business

    Advanced Enzymes Technologies Limited is the largest Indian enzyme company focusing on research, development, and manufacturing of enzymes and probiotics. Their aim is to provide side-effect free healthcare solutions, improve animal nutrition, and promote enzyme-based industrial processes.

    Advanced Enzyme Tech major competitors are Fermenta Biotech, Concord Biotech, Biocon, Guj. Themis Biosyn, Zota Health Care, Gufic Biosciences, Novartis.
    Market Cap of Advanced Enzyme Tech is ₹4,178 Crs.
    While the median market cap of its peers are ₹4,175 Crs.

    Advanced Enzyme Tech seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Feb May May Aug Nov Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Mar Jun Mar Jun Sep Dec Sep Dec
    Investor Presentation Jan May May Aug Sep Nov Mar Jun Sep Dec Mar Jun Sep Dec Feb Mar May Jun Aug Sep Dec Mar May Sep Dec Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Mar Sep Dec Sep Dec
    Conference Call Feb May Mar Aug Nov Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Sep Dec Mar Jun Sep Dec Mar Jun Sep Mar Jun Sep Dec Sep Dec
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Advanced Enzyme Technologies Ltd.
    View the discussion on ValuePickr
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material